Campaign news

Worried about your blank moments?

Blog, News | No Comments 4th January 2012

If so we are the only northern NHS Trust to be taking part in a new, exciting study to determine whether a new drug slows down memory loss or other symptoms associated with prodromal Alzheimer’s disease (prodromal AD).

Prodromal AD is a condition in which a person’s memory loss is worse than can be expected by the normal ageing process alone. Typically, their ability to get on with daily activities is not affected so much that they would be diagnosed with dementia.

In the past, people with prodromal AD would have been considered to be showing symptoms of old age or would have been given a diagnosis of mild cognitive impairment (MCI). Today prodromal AD is becoming a recognised condition. We now know that people who have prodromal AD may be more likely to develop dementia than people with other forms of memory loss or MCI, making research studies like this one extremely important.

For that reason, we are delighted to be participating in the SCarlet RoAD study. Across 100 centres in about 15 countries we need 360 people to take part and would really appreciate your help on a local level.

We are looking for people who:

• Are aged between 50 and 85 years
• Have noticed (and someone else has noticed) a gradual decline in memory over the last 12 months
• Are not currently taking medication for dementia or Alzheimer’s disease
• Have a friend or relative who is able to say how participants are managing with daily activities and who agrees to provide information at clinic visits when appropriate
• Are interested in participating in a study that lasts for two years and five months and which will involve visits to a clinic at least once every month throughout this period

If you are interested in finding out if the Scarlet RoAD study is right for you or someone you know then visit http://scarletroadstudy.com/en-GB/index.aspx

This entry was posted on Wednesday, January 4th, 2012 at 10:50 am and is filed under Blog, News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.